IP
NBIX icon

Intellectus Partners’s Neurocrine Biosciences NBIX Stock Holding History

Intellectus Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,900
Closed -$232K – 223
2020
Q2 		$232K Buy
+1,900
New +$210K 0.09% 195
2018
Q4 		– Sell
-1,900
Closed -$234K – 438
2018
Q3 		$234K Hold
1,900
– – 0.08% 221
2018
Q2 		$187K Hold
1,900
– – 0.07% 226
2018
Q1 		$158K Hold
1,900
– – 0.05% 245
2017
Q4 		$147K Hold
1,900
– – 0.05% 244
2017
Q3 		$116K Hold
1,900
– – 0.05% 281
2017
Q2 		$87K Hold
1,900
– – 0.04% 290
2017
Q1 		$82K Hold
1,900
– – 0.04% 270
2016
Q4 		$74K Buy
+1,900
New +$86K 0.04% 267

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return